CD19-BAFF Targeted CAR T-cells

BIOLOGICAL2 trials

Sponsors

Zhejiang University

Conditions

Acute Lymphoblastic Leukemia,B-CellAutoimmune DiseasesNon-hodgkin Lymphoma,B Cell

Early Phase 1

CD19-BAFF CAR-T Cells Therapy for Patients With Autoimmune Diseases

RecruitingNCT06279923

Zhejiang UniversityAutoimmune Diseases

Start: 2024-04-15End: 2027-02-01Target: 45Updated: 2024-04-09

CD19-BAFF CAR-T Cells Therapy for Patients With Relapsed / Refractory B-cell ALL and B-cell NHL

RecruitingNCT06346912

Zhejiang UniversityAcute Lymphoblastic Leukemia,B-Cell, Non-hodgkin Lymphoma,B Cell

Start: 2024-05-30End: 2027-05-30Target: 20Updated: 2024-05-14